TissueForm
Developer of human tissue–derived biomaterial implants designed to preserve native extracellular matrix architecture for durable structural repair. The company positions a flowable, injectable allograft platform for cosmetic soft-tissue augmentation and load-bearing cartilage repair, and emphasizes cGMP manufacturing, regulatory planning, and preclinical demonstration to support clinical translation.
Industries
Nr. of Employees
small (1-50)
Products
Allovia Cosmetic
A flowable, transdermal filler derived from human tissue extracellular matrix designed to provide immediate structural lift and long-term structural integration while allowing reversibility.
Allovia Cartilage
A flowable allograft material intended for arthroscopic delivery into cartilage defects, designed to be load-bearing and durable for orthopedic repair.
Platform biomaterial technology
A modular human tissue-derived biomaterial platform intended to be adapted across multiple indications where preserved native 3D structure and integration are critical.
Allovia
Allovia is an engineered tissue repair product made from human tissue that preserves native proteins, structure, and architecture to support long-term tissue function and healing. It is injectable, flowable, conforms to complex defects, crosslinks in place without glue, and is durable and shelf-stable for clinical use.
Allovia Cosmetic
A flowable, transdermal filler derived from human tissue extracellular matrix designed to provide immediate structural lift and long-term structural integration while allowing reversibility.
Allovia Cartilage
A flowable allograft material intended for arthroscopic delivery into cartilage defects, designed to be load-bearing and durable for orthopedic repair.
Platform biomaterial technology
A modular human tissue-derived biomaterial platform intended to be adapted across multiple indications where preserved native 3D structure and integration are critical.
Allovia
Allovia is an engineered tissue repair product made from human tissue that preserves native proteins, structure, and architecture to support long-term tissue function and healing. It is injectable, flowable, conforms to complex defects, crosslinks in place without glue, and is durable and shelf-stable for clinical use.
Expertise Areas
- Biomaterials and extracellular matrix-based implants
- Tissue engineering and regenerative medicine
- Preclinical model development
- cGMP manufacturing for biologic/allograft products
Key Technologies
- Decellularized human extracellular matrix (ECM) biomaterials
- Flowable/injectable biomaterial formulations
- In situ crosslinking biomaterials
- cGMP-compatible tissue processing